Introduction
Human CDH6 (Cadherin-6) is a transmembrane glycoprotein that belongs to the cadherin family of cell adhesion molecules. It is expressed in various tissues, including the brain, kidney, and heart, and plays a crucial role in cell-cell adhesion and signaling. The HEK293T stable cell line expressing Human CDH6 is a valuable tool for studying the structure, activity, and potential therapeutic applications of this important protein.
Structure of Human CDH6
Human CDH6 is a type II classical cadherin with a single transmembrane domain and a large extracellular domain. The extracellular domain consists of five cadherin repeats, which are responsible for calcium-dependent homophilic interactions with other cadherin molecules. The cytoplasmic domain of CDH6 contains conserved motifs that mediate interactions with the cytoskeleton and signaling molecules.
Activity of Human CDH6
The main function of Human CDH6 is to mediate cell-cell adhesion through homophilic interactions. This adhesion is crucial for the maintenance of tissue integrity and the regulation of cell behavior, including cell proliferation, differentiation, and migration. In addition, CDH6 has been shown to play a role in cell signaling pathways, such as the Wnt/β-catenin pathway, which is involved in embryonic development and tumorigenesis.
Application of Human CDH6 HEK293T Stable Cell Line
The HEK293T stable cell line expressing Human CDH6 has several applications in scientific research, including:
1. Studying the role of CDH6 in cell adhesion and signaling
The stable cell line provides a consistent and reliable source of Human CDH6, allowing researchers to investigate its function in cell adhesion and signaling. This can be done through various techniques, such as flow cytometry, immunofluorescence, and western blotting.
2. Screening potential therapeutic agents targeting CDH6
CDH6 has been identified as a potential therapeutic target in various diseases, including cancer. The stable cell line can be used to screen and evaluate potential therapeutic agents that target CDH6, such as antibodies or small molecule inhibitors. This can aid in the development of new treatments for diseases associated with CDH6 dysregulation.
3. Investigating the role of CDH6 in disease progression
The overexpression of CDH6 has been linked to the progression of certain cancers, making it a potential prognostic marker. The stable cell line can be used to study the role of CDH6 in disease progression and its potential as a biomarker for cancer diagnosis and prognosis.
4. Developing in vitro models for cell adhesion and migration studies
The HEK293T stable cell line expressing Human CDH6 can be used to develop in vitro models for studying cell adhesion and migration. This can aid in understanding the mechanisms of these processes and their dysregulation in diseases.
5. Investigating the role of CDH6 in embryonic development
CDH6 has been shown to play a critical role in embryonic development, particularly in the development of the central nervous system. The stable cell line can be used to study the function of CDH6 in embryonic development and its potential implications for developmental disorders.
Conclusion
In summary, the HEK293T stable cell line expressing Human CDH6 is a valuable tool for studying the structure, activity, and potential therapeutic applications of this important protein. Its applications in various research areas make it a valuable resource for understanding the role of CDH6 in health and disease.
There are no reviews yet.